Adverum Biotechnologies

Adverum Biotechnologies is a clinical-stage gene therapy company focused on addressing unmet medical needs in ophthalmology and rare diseases. We develop gene therapy candidates designed to provide long-lasting efficacy through the sustained expression of therapeutic proteins. Our core competencies include clinical development, novel vector discovery, and internal manufacturing expertise, particularly in scalable process development, analytical development, and current Good Manufacturing Practice (cGMP) quality control. Our team has extensive experience in clinical development and is dedicated to advancing new gene therapies for patients.